Affiliate membership will open doors for TRHC in the community pharmacy arena
MOORESTOWN, N.J., Oct. 12, 2021 –Tabula Rasa HealthCare, Inc.® (TRHC) (NASDAQ: TRHC), a leading healthcare technology company advancing the safe use of medications, announced today its acceptance to the World Pharmacy Council as an affiliate member, emphasizing TRHC’s commitment to serving community pharmacists.
Established in 2017, the World Pharmacy Council drives research and discussion surrounding community pharmacy. Its mission is to build international recognition of community pharmacy, its role, policies, and value, and to influence, promote, and secure acceptance of community pharmacy as an important and integral part of health systems. Affiliate members provide support and services to community pharmacy and share their unique perspectives and expertise to help the World Pharmacy Council deliver on its mission. TRHC will take part in World Pharmacy Council meetings, leverage council data and analysis, and connect with global community pharmacy leaders.
“Community pharmacists are essential to advancing medication safety. We are committed to providing pharmacists with the best tools, such as TRHC’s unique MedWise® technology, to help pharmacists quickly identify patients who are most at risk for adverse drug events (ADEs) that cause millions of avoidable emergency room visits and hospital stays each year, helping to drive better health outcomes at lower costs,” said TRHC Chairman and CEO Calvin H. Knowlton, PhD. “Through the World Pharmacy Council, we can share our resources and expertise with more leaders in community pharmacy on a global scale.”
“The World Pharmacy Council is delighted to welcome TRHC as an affiliate member,” said Doug Hoey, RPh, MBA, President of the World Pharmacy Council. “Our member organizations are keen to adopt technology that leads to improved patient care and TRHC will be a valued partner in developing community pharmacy services internationally.”
To learn more about how TRHC empowers community pharmacies, visit us online here.
About Tabula Rasa HealthCare
Tabula Rasa HealthCare (TRHC) (NASDAQ: TRHC) provides medication safety solutions that empower healthcare professionals and consumers to optimize medication regimens, combatting medication overload and reducing adverse drug events – the fourth leading cause of death in the US. TRHC’s proprietary technology solutions, including MedWise®, improve patient outcomes, reduce hospitalizations, and lower healthcare costs. TRHC’s extensive clinical tele-pharmacy network improves care for patients nationwide. Its solutions are trusted by health plans and pharmacies to help drive value-based care. For more information, visit TRHC.com.
This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements give current expectations or forecasts of future events or the Company’s future financial or operating performance, and include the Company’s expectations regarding healthcare regulations, industry trends, available opportunities to the Company, the financial and operating performance of the Company, the impacts of the COVID-19 pandemic, and the Company’s expectations for 2021 and beyond. Such statements are identified by use of the words “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “should,” and similar expressions. These forward-looking statements are based on management’s good-faith expectations, judgements, and assumptions as of the date of this Report. Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include: the impacts of the ongoing COVID-19 pandemic and other health epidemics; fluctuations in the Company’s financial results; the acceptance and use of the Company’s products and services by PACE organizations; the need to innovate and provide useful products and services; risks related to changing healthcare and other applicable governmental regulations; the Company’s ability to maintain relationships with a specified drug wholesaler; increasing consolidation in the healthcare industry; managing the Company’s growth effectively; the Company’s ability to adequately protect its intellectual property; the requirements of being a public company; the Company’s ability to recognize the expected benefits from acquisitions on a timely basis or at all; and the other risk factors set forth from time to time in the Company’s filings with the Securities and Exchange Commission (“SEC”), including those factors discussed under the caption “Risk Factors” in its most recent annual report on Annual Report on Form 10-K, filed with the SEC on February 26, 2021, and in subsequent reports filed with or furnished to the SEC. The Company assumes no obligation and does not intend to update these forward-looking statements, except as required by law, to reflect events or circumstances occurring after today’s date.
T: (908) 380-2143